Breast cancer is commonly separated into Luminal A (LumA), Luminal B (LumB), epidermal growth factor receptor ERBB2/HER2-overexpressing (HER2+), and basal epithelial-like (BL) based on gene expression profiles [5]. This evidence concerns the gene ERBB2 and breast carcinoma.